Hovione's $35M CDC Flex line links spray drying to tablets, designed to eliminate scale-up under FDA Q13 guidance.
|Articles|February 26, 2016
PTSM: Pharmaceutical Technology Sourcing and Management
- PTSM: Pharmaceutical Technology Sourcing and Management-03-02-2016
- Volume 11
- Issue 3
Benchtop Centrifuge Features Hybrid Rotor
The Medifuge small benchtop centrifuge from Thermo Scientific provides versatility within a compact footprint.
Advertisement
The Thermo Scientific Medifuge benchtop centrifuge features a 2-in-1 hybrid DualSpin rotor that has interchangeable fixed-angle and swinging buckets to facilitate switching between applications provides the flexibility to perform several applications on a single platform.
The centrifuge incorporates safety and environmental sustainability features such as an emergency lid-lock release; operation at less than 56 dBA; and a lightweight composite rotor.
The centrifuge features a display with intuitive controls and a one-click closure. The four customizable programs allow users to run routine protocols; three deceleration profiles – standard, soft and brake-off – are designed to provide optimal separation.
The centrifuge can accommodate tubes, from 1.4 mL to 15 mL, with two spacer options.
Source:
Articles in this issue
over 10 years ago
Small-Scale Modeling Boosts Downstream Developmentover 10 years ago
Technologies Expand Horizons of the Analytical Labover 10 years ago
Global Conflicts and CMO Impactsover 10 years ago
Hazardous Reagents for Higher Yieldsover 10 years ago
Mechanical Pipettes Have Ergonomic Designover 10 years ago
Cirrus Pharmaceuticals Announces Manufacturing for Clinical Trialsover 10 years ago
ICIG Acquires Sandoz Site in Germanyover 10 years ago
Recipharm Acquires Italian CDMOover 10 years ago
Patheon Signs Strategic Agreement with GrünenthalAdvertisement
Related to this article
This week on PharmTech, Merck diversified its pipeline, USP emphasizes supply chain security, AI systems are examined, and speakers preview their presentations at CPHI Milan and AAPS PharmSci 360.
Capsugel's Bram Baert and Sandrine Picco argue that chasing zero nitrite in pharmaceutical excipients is often impractical and costly. They recommend setting scientifically justified, risk-based limits and consistently staying below them.
Ron Scarboro, Azurity Pharmaceuticals, claims drug reformulation that removes patient barriers must preserve efficacy, urging early cross-functional team alignment.
PharmTech AI Pulse Check episode 2 covers AI data governance, API-gated journals, watermarking limits, and why attribution beats detection in GxP.
The FDA opened an expedited IND pilot, tightened scrutiny of foreign trial data, and finalized a rule recognizing non-animal testing methods. In Europe, the EMA advanced pharmaceutical legislation reform, restricted 2 legacy products, and opened an injectable-iron safety review.
Novartis licenses Abogen's mRNA-encoded T-cell engager for autoimmune disease, raising scale-up questions for mRNA-lipid nanoparticle manufacturing.
Pharma manufacturing spent 90 years learning that producing correct outputs isn't the same as catching your own errors. AI has only learned the first.
Advertisement
Advertisement